NCT00966914 2022-07-13
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
BioNumerik Pharmaceuticals, Inc.
Phase 3 Completed